GlaxoSmithKline Study Shows Its Cancer Shot Beats Merck & Co., Inc.'s (JOBS)
Reuters -- GlaxoSmithKline's vaccine Cervarix produces a more powerful immune response against a sexually transmitted virus that causes cervical cancer than Merck & Co's rival Gardasil, research showed on Friday.